Free Trial
NASDAQ:NAMSW

NewAmsterdam Pharma (NAMSW) Stock Price, News & Analysis

$7.62 +0.37 (+5.16%)
As of 04/17/2025 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About NewAmsterdam Pharma Stock (NASDAQ:NAMSW)

Key Stats

Today's Range
$7.16
$8.55
50-Day Range
$6.15
$12.91
52-Week Range
$5.45
$16.75
Volume
3,432 shs
Average Volume
5,054 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease. It is developing obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer's disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.

Receive NAMSW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NewAmsterdam Pharma and its competitors with MarketBeat's FREE daily newsletter.

NAMSW Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

NAMSW Stock Analysis - Frequently Asked Questions

NewAmsterdam Pharma's stock was trading at $14.25 at the beginning of the year. Since then, NAMSW stock has decreased by 46.6% and is now trading at $7.6110.
View the best growth stocks for 2025 here
.

Shares of NAMSW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:NAMSW
Fax
N/A
Employees
29
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$45.56 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:NAMSW) was last updated on 4/20/2025 by MarketBeat.com Staff
From Our Partners